April's El Dorados: Rock-Solid Stocks

This article is part of our Rising Star Portfolios series.

I kicked off my multivitamin Rising Star portfolio by buying a stock that I hope will anchor my portfolio for decades to come. Only a "corporate El Dorado" would fit the bill, and in my case, that turned out to be Coca-Cola. Each month I'll be running my screen to give you a list of more of these world-beating companies to consider.

I'm also tracking and scoring each one of my monthly screens now, so we can see exactly how they're performing. More on that in a moment.

But first...

Corporate what?
Wharton professor Jeremy Siegel came up with the term "corporate El Dorado" while studying the common characteristics of the greatest stocks in S&P 500 history. He found that 97% of the total after-inflation accumulation from stocks came from reinvesting dividends.

Dividend-paying stocks act, in Siegel's words, as "bear-market protectors" and "return accelerators." When dividends get reinvested, they purchase more and more shares at lower prices during a bear market. These extra shares act as a bear-market protector. Then, when stock prices head back up, the extra shares act as a return accelerator and rocket total returns higher.

If you need more proof, consider that the 20 best-performing survivor stocks in Siegel's study from the original S&P 500 in 1957 are all dividend payers -- names such as Altria, Abbott Labs, Bristol-Myers Squibb, and Tootsie Roll Industries, as well as Coca-Cola. Altria, as Philip Morris, was the top performer in Siegel's 1957-2003 study period, with an incredible annualized return of 19.75%. That was enough to turn an original $1,000 investment into $4.6 million!

Elements of greatness
Siegel also found some other common characteristics among these 20 corporate El Dorados. The most important is the ability to deliver greater-than-expected earnings growth on a consistent basis. Carrying an average price-to-earnings ratio slightly above the market average, these companies weren't exactly cheap on a traditional basis. But throughout the years, they always seemed to deliver a bit more than the market expected.

Also, most of the top 20 marketed famous consumer brands and pharmaceuticals. Brands like Coke and Wrigley have strong moats because of products that consumers are willing to pay a little bit more for. As Charlie Munger once described, if you walk into a store and see Wrigley chewing gum selling for $0.40 and Glotz's gum selling for $0.30, you're not going to flinch at paying that extra "lousy dime" for a product you know and trust. But those dimes add up significantly for Wrigley over time!

Putting it all together
Enough preamble; it's time for the screen. Remember, we want large caps with a history of dividend increases. We want companies with strong balance sheets, so we don't have to worry about them getting into any trouble during hard times (as so many companies did in our most recent crisis). We also want businesses with a track record of consistent earnings and dividend growth.

I start the screening with all companies on major U.S. exchanges with a dividend yield of at least 1%. Here are the rest of the criteria:

  1. Market cap greater than $20 billion.
  2. Total debt-to-capital ratio less than 60%.
  3. Average annual earnings-per-share growth over the past 10 years greater than 5%.
  4. Projected annual earnings-per-share growth over the next five years greater than 5%.
  5. Positive dividend growth over the past five years.

A total of 80 companies passed the screen, and I'll post the complete list on my Rising Star discussion board. As you look through the companies, you'll see several that practically shout "I'm an El Dorado!" at you. The strong consumer brands such as Coke and PepsiCo, McDonald's, Kraft Foods, and ExxonMobil. The pharmaceuticals and consumer goods producers like Abbott Labs, Teva Pharmaceutical (Nasdaq: TEVA  ) , Johnson & Johnson, Procter & Gamble (NYSE: PG  ) , and 3M (NYSE: MMM  ) .

There are also a few that carry more risk but have greater potential reward, including PotashCorp (NYSE: POT  ) and Intel (Nasdaq: INTC  ) .

You'll need to stay in your comfort zone, and realize these are stocks meant to anchor your portfolio and be held for the long term. Just drop any questions you have on the discussion board.

Follow along
All the passing companies are getting a thumbs-up CAPScall from me. To keep up with the screen's performance, make this CAPS profile one of your favorites.

You can stay on top of my buys and sells and all my meandering ruminations on Twitter. You can also add any of these candidates to your free, personalized watchlist by clicking the appropriate link below.

Fool analyst Rex Moore is fearfully referred to as "Mr. El Dorado" by his co-workers. He owns shares of Procter & Gamble and Johnson & Johnson. The Motley Fool owns shares of PepsiCo, Intel, Johnson & Johnson, Abbott Laboratories, and Coca-Cola. Motley Fool newsletter services have recommended buying shares of PepsiCo, 3M, Johnson & Johnson, ExxonMobil, Intel, Teva Pharmaceutical Industries, Procter & Gamble, Coca-Cola, McDonald's, and PotasCorp. Motley Fool newsletter services have recommended creating diagonal call positions in Johnson & Johnson, 3M, and PepsiCo. The Motley Fool has a disclosure policy.

We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. Try any of our Foolish newsletter services free for 30 days.


Read/Post Comments (0) | Recommend This Article (1)

Comments from our Foolish Readers

Help us keep this a respectfully Foolish area! This is a place for our readers to discuss, debate, and learn more about the Foolish investing topic you read about above. Help us keep it clean and safe. If you believe a comment is abusive or otherwise violates our Fool's Rules, please report it via the Report this Comment Report this Comment icon found on every comment.

Be the first one to comment on this article.

Sponsored Links

Leaked: Apple's Next Smart Device
(Warning, it may shock you)
The secret is out... experts are predicting 458 million of these types of devices will be sold per year. 1 hyper-growth company stands to rake in maximum profit - and it's NOT Apple. Show me Apple's new smart gizmo!

DocumentId: 1861662, ~/Articles/ArticleHandler.aspx, 8/21/2014 2:20:29 AM

Report This Comment

Use this area to report a comment that you believe is in violation of the community guidelines. Our team will review the entry and take any appropriate action.

Sending report...

Apple's next smart device (warning, it may shock you

Apple recently recruited a secret-development "dream team" to guarantee its newest smart device was kept hidden from the public for as long as possible. But the secret is out. In fact, ABI Research predicts 485 million of this type of device will be sold per year. But one small company makes Apple's gadget possible. And its stock price has nearly unlimited room to run for early-in-the-know investors. To be one of them, and see Apple's newest smart gizmo, just click here!


Advertisement